Category Archives: Technology

Digital MRO Market Research Report by Technology (3D Printing, AR/VR, Artificial Intelligence, Big Data Analytics, and Blockchain), by End User (Airlines, MROs, and OEMs), by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19

New York, March 11, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Digital MRO Market Research Report by Technology, by End User, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06034045/?utm_source=GNW

Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Digital MRO Market is expected to grow from USD 595.23 Million in 2020 to USD 872.67 Million by the end of 2025.2. The Global Digital MRO Market is expected to grow from EUR 521.90 Million in 2020 to EUR 765.17 Million by the end of 2025.3. The Global Digital MRO Market is expected to grow from GBP 463.97 Million in 2020 to GBP 680.24 Million by the end of 2025.4. The Global Digital MRO Market is expected to grow from JPY 63,526.12 Million in 2020 to JPY 93,136.00 Million by the end of 2025.5. The Global Digital MRO Market is expected to grow from AUD 864.35 Million in 2020 to AUD 1,267.23 Million by the end of 2025.

Market Segmentation & Coverage:This research report categorizes the Digital MRO to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Technology, the Digital MRO Market studied across 3D Printing, AR/VR, Artificial Intelligence, Big Data Analytics, Blockchain, Digital Twin, Internet of Things (IoT), Predictive Maintenance, and Robotics.

Based on End User, the Digital MRO Market studied across Airlines, MROs, and OEMs.

Based on Application, the Digital MRO Market studied across Inspection, Mobility & Functionality, Part Replacement, Performance Monitoring, and Predictive Analysis.

Based on Geography, the Digital MRO Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Digital MRO Market including Airbus SAS, ANSYS, Inc., Atheer, Inc., AV-BASE Systems, Inc., Capgemini SE, Collins Aerospace, EON Reality, HCL Technologies Limited, Hexaware Technologies Ltd, Honeywell International Inc., IBS Software, IFS AB, L&T Technology Services Limited., Lufthansa Technik AG, Magic Leap, Inc., Oracle Corporation, PTC Inc., Ramco Systems Limited, Rusada Inc, SAP SE, SITA, Swiss AviationSoftware Ltd., The Boeing Company, and TRAXXALL Technologies.

Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Digital MRO Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:1. What is the market size and forecast of the Global Digital MRO Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Digital MRO Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Digital MRO Market?4. What is the competitive strategic window for opportunities in the Global Digital MRO Market?5. What are the technology trends and regulatory frameworks in the Global Digital MRO Market?6. What are the modes and strategic moves considered suitable for entering the Global Digital MRO Market?Read the full report: https://www.reportlinker.com/p06034045/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Story continues

Read more:

Digital MRO Market Research Report by Technology, by End User, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19 - Yahoo...

CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA) technology, is pleased to share that researchers at Northwestern University have utilized Exicures licensed first generation gold-nanoparticle SNA technology in an investigator-initiated trial for the treatment of glioblastoma (GBM), a deadly form of brain cancer.

The results were published in an article in Science Translational Medicine. https://stm.sciencemag.org/content/13/584/eabb3945 DOI:10.1126/scitranslmed.abb3945

The researchers that led the study, Drs. Priya Kumthekar and Alexander Stegh, conducted a single-arm, open-label phase 0 first-in-human clinical trial (NCT03020017) to determine safety, pharmacokinetics, intratumoral accumulation and gene-suppressive activity of systemically administered SNAs comprised of siRNA specific for the GBM oncogene Bcl2L12. Patients with recurrent GBM were treated with intravenous administration of siBcl2L12-SNAs (NU-0129).

The paper reports first-in-human evidence that siRNA-based SNAs can be administered intravenously, cross the blood-brain-barrier in glioblastoma patients, accumulate in GBM tumor cells, and engage with their target gene.

We congratulate Drs. Kumthekar and Stegh on these results, said Dr. David Giljohann, the CEO of Exicure. He added, We are excited about the impact to patients and its implications in treating other diseases, as Exicure continues to build and grow our pipeline in neurological disorders.

Exicure anticipates filing an IND for its lead program in Friedreichs ataxia by the end of 2021.

About Glioblastoma

Glioblastoma (GBM) is the most common and most aggressive type of primary malignant tumor of the central nervous system. The global incidence of glioblastoma is less than 10 per 100,000 people. Standard treatment for patients with newly diagnosed glioblastoma can include surgery followed by radiation and chemotherapy, but treatment options are limited. The last investigational medicine to improve survival for patients with newly diagnosed glioblastoma was approved by the U.S. Food and Drug Administration in 2005. The five-year survival rate of patients with GBM is less than five percent.

About Friedreichs Ataxia

Friedreichs ataxia (FA) is the most commonly inherited ataxia, a degenerative neuromuscular disease leading to progressive loss of coordination, causing severe childhood disability and early mortality, in most cases before age 40. It is a monogenic disorder caused by mutations in the FXN gene resulting in reduced levels of frataxin protein. FA affects about 13,500 people in the US, Europe, Canada and Australia combined. There are currently no approved therapies for Friedreichs ataxia patients.

About Exicure, Inc.

Exicure, Inc. is a clinical-stage biotechnology company developing therapeutics for neurology, immuno-oncology, inflammatory diseases and other genetic disorders based on our proprietary Spherical Nucleic Acid, or SNA technology. Exicure believes that its proprietary SNA architecture has distinct chemical and biological properties that may provide advantages over other nucleic acid therapeutics and may have therapeutic potential to target diseases not typically addressed with other nucleic acid therapeutics. Exicure is in preclinical development of XCUR-FXN a lipid-nanoparticle SNAbased therapeutic candidate, for the intrathecal treatment of Friedreichs ataxia (FA). Exicure's therapeutic candidate cavrotolimod (AST-008) is in a Phase 1b/2 clinical trial in patients with advanced solid tumors. Exicure is based in Chicago, IL and in Cambridge, MA.

For more information, visit Exicures website at http://www.exicuretx.com.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements in this press release other than statements of historical fact could be deemed forward looking including, but not limited to, the initiation, timing and results of the Companys preclinical studies and clinical trials, including its lead program in Friedreichs ataxia; and the potential of the Companys SNA technology to provide therapeutic benefit to target diseases, including its ability to address the genetic challenges posed by Friedreichs ataxia and other neurological conditions. The forward-looking statements in this press release speak only as of the date of this press release, and the Company undertakes no obligation to update these forward-looking statements. Forward-looking statements are based on managements current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: the risks that the ongoing coronavirus disease 2019, or COVID-19, pandemic or its impact or effects may disrupt the Companys business and/or the global healthcare system (including its supply chain) more severely than it has to date or more severely than anticipated; unexpected costs, charges or expenses that reduce the Companys capital resources; the Companys preclinical or clinical programs do not advance or result in approved products on a timely or cost effective basis or at all; the cost, timing and results of clinical trials; that many drug candidates do not become approved drugs on a timely or cost effective basis or at all; the ability to enroll patients in clinical trials; possible safety and efficacy concerns; regulatory developments; risks that preliminary results from clinical trials are not necessarily predictive of future clinical trial results; and the ability of the Company to protect its intellectual property rights. For a discussion of other risks and uncertainties, and other important factors, any of which could cause the Companys actual results to differ from those contained in the forward-looking statements, see the section titled Risk Factors in the Companys Annual Report on Form 10-K for the year ended December 31, 2020, which is expected to be filed on or approximately on the same date hereof, as updated by the Companys subsequent filings with the Securities and Exchange Commission. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information, except as required by law. In addition, the COVID-19 pandemic and the associated containment efforts have had and continue to have a serious adverse impact on the economy, the severity and duration of which are uncertain. Government stabilization efforts have only partially mitigated the consequences. The extent and duration of the impact on the Companys business and operations is highly uncertain, and that impact includes effects on its clinical trial operations, timelines and supply chain. Factors that will influence the impact on the Companys business and operations include the duration and extent of the pandemic, the extent of imposed or recommended containment and mitigation measures, and the general economic consequences of the pandemic. The COVID-19 pandemic or its impact or effects could have a material adverse impact on the Companys business, operations and financial results for an extended period of time.

Follow this link:

Spherical Nucleic Acid Technology Shows Promising Results in Phase 0 Trial in Patients With Glioblastoma at Northwestern University - Business Wire

ALPHARETTA, Ga., March 10, 2021 /PRNewswire/ --Priority Technology Holdings, Inc. (NASDAQ: PRTH) ("Priority" or the "Company"), a leading provider of merchant acquiring, integrated payment software and commercial payment solutions, today announced that it is participating in the 33rdAnnual Roth Conference on March 15, 2021. Priority's Chairman and Chief Executive Officer Tom Priore and other company representatives will participate in one-on-one meetings with investors and analysts during the conference. To schedule a one-on-one meeting with Priority, please contact your Roth representative. A copy of the investor presentation will be available on our website on March 15, 2021.In these meetings, the Company may be discussing the following unaudited fourth quarter and full year 2020 financial results and financial guidance for 2021.

Fourth Quarter 2020 Unaudited ResultsFinancial highlights of the fourth quarter of 2020 compared with the fourth quarter of 2019, are as follows:

The fourth quarter of 2019 includes the results of the RentPayment business sold to MRI Software ("MRI") in September 2020. The fourth quarter of 2020 results compared with the fourth quarter of 2019, excluding the RentPayment business, are as follows:

Full Year 2020 Unaudited ResultsFinancial highlights of the full year 2020 compared with the full year 2019, are as follows:

The consolidated results include the results of the RentPayment business from March 1, 2019 through September 22, 2020. The results for full year 2020 compared with the results for full year 2019, excluding the RentPayment business, are as follows:

Full Year 2021 Financial GuidanceThe Company expects the full year 2021 results, before any increases related to its anticipated acquisition of Finxera Holdings, Inc., to include:

(1) See "Non-GAAP Financial Measures" and the reconciliations of Adjusted EBITDA to their most comparable GAAP measures provided within the attached financial schedules.

Results With and Without RentPayment

Summary reconciliations of actual financial results for each quarter and full year 2020 (unaudited) and 2019 with actual results excluding the RentPayment business sold in September 2020 are included within the attached financial schedules.

Non-GAAP Financial Measures

This communication includes certain non-GAAP financial measures that we regularly review to evaluate our business and trends, measure our performance, prepare financial projections, allocate resources, and make strategic decisions. We believe these non-GAAP measures help to illustrate the underlying financial and business trends relating to our results of operations and comparability between current and prior periods. We also use these non-GAAP measures to establish and monitor operational goals. However, these non-GAAP measures are not superior to or a substitute for prominent measurements calculated in accordance with GAAP. Rather, the non-GAAP measures are meant to be a complement to understanding measures prepared in accordance with GAAP.

EBITDA, Adjusted EBITDA and Consolidated Adjusted EBITDA

EBITDA and adjusted EBITDA are performance measures. EBITDA is earnings before interest, income tax, and depreciation and amortization expenses ("EBITDA"). Adjusted EBITDA begins with EBITDA but further excludes certain non-cash costs, such as stock-based compensation and the write-off of the carrying value of investments or other assets, as well as debt extinguishment and modification expenses and other expenses and income items considered non-recurring, such as acquisition integration expenses, certain professional fees, and litigation settlements. Consolidated adjusted EBITDA, which is a liquidity measure used in determining our total net leverage ratio, is adjusted EBITDA further adjusted for items specified in the definition of consolidated adjusted EBITDA within our debt agreements, which include the pro-forma impact of acquisitions and dispositions and other specified adjustments. We review the non-GAAP adjusted EBITDA measure to evaluate our business and trends, measure our performance, prepare financial projections, allocate resources, and make strategic decisions. We review the non-GAAP consolidated adjusted EBITDA to evaluate compliance with our total net leverage ratio at each measurement period.

The reconciliation of adjusted EBITDA to its most comparable GAAP measure is provided within the attached financial schedules.

Priority does not provide a reconciliation of forward-looking non-GAAP financial measures to their comparable GAAP financial measures because it could not do so without unreasonable effort due to the unavailability of the information needed to calculate reconciling items and due to the variability, complexity and limited visibility of the adjusting items that would be excluded from the non-GAAP financial measures in future periods. When planning, forecasting and analyzing future periods, the Company does so primarily on a non-GAAP basis without preparing a GAAP analysis as that would require estimates for various cash and non-cash reconciling items that would be difficult to predict with reasonable accuracy. For example, stock-based compensation expense would be difficult to estimate because it depends on the Company's future hiring and retention needs, as well as the future fair market value of the Company's common stock, all of which are difficult to predict and subject to constant change. As a result, the Company does not believe that a GAAP reconciliation would provide meaningful supplemental information about the Company's outlook.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future financial and operating results, our plans, objectives, expectations and intentions with respect to future operations, products and services, and other statements identified by words such as "may," "will," "should," "anticipates," "believes," "expects," "plans," "future," "intends," "could," "estimate," "predict," "projects," "targeting," "potential" or "contingent," "guidance," "anticipates," "outlook" or words of similar meaning. These forward-looking statements include, but are not limited to, our 2021 outlook. Such forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive risks, trends and uncertainties that could cause actual results to differ materially from those projected, expressed, or implied by such forward-looking statements. These forward-looking statements may include, but are not limited to, statements about the effects of the COVID-19 pandemic on our revenues and financial operating results. Our actual results could differ materially, and potentially adversely, from those discussed or implied herein.

We caution that it is very difficult to predict the impact of known factors, and it is impossible for us to anticipate all factors that could affect our actual results. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. You should evaluate all forward-looking statements made in this press release in the context of the risks and uncertainties disclosed in our Securities and Exchange Commission ("SEC") filings, including our Annual Report on Form 10-K and our Quarterly Report on Form 10-Q filed with the SEC on March 30, 2020 and November 13, 2020, respectively. These filings are available online at http://www.sec.gov or http://www.PRTH.com.

We caution you that the important factors referenced above may not contain all of the factors that are important to you. In addition, we cannot assure you that we will realize the results or developments we expect or anticipate or, even if substantially realized, that they will result in the consequences we anticipate or affect us or our operations in the way we expect. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law. If we do update one or more forward-looking statements, no inference should be made that we will make additional updates with respect to those or other forward-looking statements. We qualify all of our forward-looking statements by these cautionary statements.

PRIORITY TECHNOLOGY HOLDINGS, INC.

Non-GAAP Financial Measures

Unaudited

(in thousands)

(in thousands)

Twelve Months Ended December 31, 2020

Twelve Months Ended December 31, 2019

Consolidated

RentPayment

Excl RentPayment

Consolidated

RentPayment

Excl RentPayment

Revenues

$

404,342

$

12,042

$

392,300

$

371,854

$

11,694

$

360,160

Operating Expenses:

Costs of services

277,374

1,362

276,012

252,569

1,166

251,403

Salary and employee benefits

39,507

1,649

37,858

42,214

882

41,332

Depreciation and amortization

40,775

3,668

37,107

39,092

4,031

35,061

Selling, general and administrative

25,825

3,538

22,287

30,795

3,340

27,455

Total operating expenses

383,481

10,217

373,264

364,670

9,419

355,251

Income from operations

20,861

1,825

19,036

7,184

2,275

4,909

Depreciation and amortization

40,775

3,668

37,107

39,092

4,031

35,061

Other income, net

807

807

710

Follow this link:

Priority Technology Holdings, Inc. to Participate in the 33rd Annual Roth Conference on March 15, 2021 - PRNewswire

WASHINGTON--(BUSINESS WIRE)--The Financial Technology Association (FTA), a new trade group formed by leaders of the technology-centered financial services industry, today announced the launch of its organization and the publication of its introductory paper, Shaping the Future of Finance. FTA will educate stakeholders and support the modernization of financial regulation to drive greater financial inclusion, equity and opportunity. Founding FTA members include Afterpay, Betterment, Brex, Carta, Figure, Marqeta, Quadpay, Plaid, Ribbit Capital, Wise and Zest AI.

FTA looks forward to engaging with the new Administration and Congress in order to help solve outstanding financial services challenges faced by many Americans, including a lack of access to fair and accessible products and financial opportunities, said Milan Dalal, FTA Senior Government Relations Advisor. The fintech industry has an important story to tell and looks forward to working with policymakers to protect consumers and advance responsible innovation.

FTA believes the successful integration of financial technology (fintech) solutions in the American financial system starts with the adoption of national policies that recognize the importance of responsible innovation and encompass a coherent vision on key priorities, which include:

Technology-driven innovation is transforming the way we offer, access, and benefit from financial services and markets in the United States, said Daniel Gorfine, FTA Senior Policy Advisor. This organization will focus on proactively shaping regulations, policy frameworks, and public understanding in order to safeguard consumers and advance the development of trusted, digital financial markets and services.

FTAs introductory paper demonstrates that fintech companies are improving efficiency and transparency, broadening equity, access and inclusion, reducing costs, and increasing choice for consumers and businesses by using internet and mobile platforms, machine learning, automation, and other modern technologies to deliver financial products and services.

These advances are coming at a critical time for the American economy, said Gorfine. Millions remain underbanked or underserved, income and wealth inequality continues to grow, and small businesses seek to rebuild from the devastation caused by the COVID-19 pandemic.

In its introductory paper, FTA outlined its key policy tracks for the US financial system, which are unified by a north star concept: the idea that safeguarding, empowering, and advancing consumer and end-user interests should drive policy formulation. Good policy should provide consumer protections, while fostering business model innovation that can deliver access to safe, inclusive, low-cost, and equitable products and services.

These policy tracks are as follows:

More information on the associations priorities, as well as the introductory paper, can be found on the FTA website: https://www.ftassociation.org/

About the Financial Technology Association

The Financial Technology Association (FTA) is the leading trade body for the technology-centered financial services industry. FTAs mission is to educate stakeholders on the value of fintech and advocate for the modernization of financial regulation to support inclusion and innovation. The organization is focused on proactively shaping regulations, policy frameworks, and public understanding in order to safeguard consumers and advance the development of trusted, digital financial markets and services.

Continue reading here:

Launch: Financial Technology Association to Advocate for Consumer-Centric Fintech Development - Business Wire

Regular readers know the name Denuvo as a once-impenetrable and now-quite-penetrable anti-piracy solution for PC games. Today, though, Denuvo parent company Irdeto announced that Denuvo technology is available to PS5 developers looking for an easy anti-cheat solution for their games.

Console gaming's closed ecosystem is generally less susceptible to the kinds of memory modifications and/or third-party cheating apps that can lead to widespread cheating in many online PC games. And while modern consoles like the Switch have seen widespread hardware hacking that makes game modding relatively simple, the PS5's ecosystem has thus far been resilient to any widely known external attacks (though hackers are already working on breaking in).

Irdeto sells its PS5 anti-cheat system as a way of "bringing fairness and fun back to gaming," but also as a revenue-protection mechanism for developers. Cheating "can lead to lower engagement, game traffic and shrinking revenues for game publishers," Denuvo Managing Director Reinhard Blaukovitsch said in a statement. Irdeto says a number of PS5 launch titles already include this technology but didn't elaborate on which ones.

Interestingly, Denuvo is selling this system both as a way to protect online gameplay and to "securely reward offline progress." That means Denuvo could be used to make sure players don't try to install strictly single-player mods that short-circuit a PS5 game's usual reward loop or try to get around in-game microtransaction payments. "Securing revenue sources beyond the game sales has become increasingly important for the publishers who rely on ad-revenues, in-game currency, downloadable content (DLC) and more broadly gamers' long-term engagement into the games," the company said in a statement.

Today's PS5 announcement comes just a few months after Irdeto launched a version of Denuvo anti-cheat protections that integrate directly with the popular Steamworks API for PC games. Last year, Denuvo also rolled out a similar product intended to protect the integrity of mobile games.

Continue reading here:

Denuvo brings its gaming anti-tampering technology to the PS5 - Ars Technica

BURLINGAME, Calif. & JERSEY CITY, N.J.--(BUSINESS WIRE)--Apex Technology Acquisition Corporation (NASDAQ: APXT, Apex) and AvePoint, the largest data management solutions provider for Microsoft 365, today announced AvePoints financial results for the full year ended December 31, 2020.

The fourth quarter was a strong finish to 2020 for AvePoint, closing out a year of record revenue, non-GAAP operating profit and operating cash flow generation. Our core subscription revenue grew 66% year-over-year, reflecting our unique market position as a leader in digital collaboration, at a time when it is a top item on every CIO's to-do list, said Dr. Tianyi TJ Jiang, CEO of AvePoint. As we look to 2021, we believe the significant growth of collaboration workflow deployments in 2020 will translate into greater need for our collaboration security and governance solutions, and we are excited about the opportunity ahead.

Fiscal Year 2020 Financial Results

Fiscal Year 2020 Key Highlights

About AvePoint

AvePoint enables customers to collaborate with confidence. Our data management solutions help our diverse, global customer base overcome complex transformation, governance, and compliance challenges in the Microsoft cloud. A five-time winner of the Global Microsoft Partner of the Year award, AvePoint offers the only full suite of SaaS solutions to migrate, manage and protect data in Microsoft 365. More than 7 million cloud users, including a quarter of the Fortune 500, rely on our solutions. Our SaaS solutions are also available to managed service providers, so they can better support and manage their small and mid-sized business customers. Our multi-tenant solutions are available from over a dozen distributors in more than 100 cloud marketplaces worldwide. For more information about AvePoint, visit https://www.avepoint.com.

About Apex Technology Acquisition Corporation

Apex is a special purpose acquisition corporation led by co-CEOs Jeff Epstein, the former CFO of Oracle, and Brad Koenig, the former head of Goldman Sachs global technology investment banking team. For more information about Apex, visit https://apexacquisitioncorp.com.

Non-GAAP Financial Measures

To supplement AvePoints consolidated financial statements presented in accordance with GAAP, the company uses non-GAAP measures of certain components of financial performance. These non-GAAP measures include non-GAAP operating income and non-GAAP operating margin. In order for AvePoints investors to be better able to compare its current results with those of previous periods, the company has included a reconciliation of GAAP to non-GAAP financial measures at the end of this press release. These reconciliations adjust the related GAAP financial measures to exclude stock-based compensation expense. AvePoint believes the presentation of its non-GAAP financial measures enhances the users overall understanding of its historical financial performance. The presentation of AvePoints non-GAAP financial measures is not meant to be considered in isolation or as a substitute for its financial results prepared in accordance with GAAP, and AvePoints non-GAAP measures may be different from non-GAAP measures used by other companies.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the federal securities laws including statements regarding AvePoints products and markets and expected future performance and market opportunities of AvePoint. These forward-looking statements generally are identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: changes in the competitive and regulated industries in which AvePoint operates, variations in operating performance across competitors, changes in laws and regulations affecting AvePoint's business and changes in AvePoints ability to implement business plans, forecasts, and to identify and realize additional opportunities, and the risk of downturns in the market and the technology industry. You should carefully consider the foregoing factors and the other risks and uncertainties described in the "Risk Factors" section of the registration statement on Form S-4 discussed below and other documents filed by Apex from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and AvePoint and Apex assume no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Neither AvePoint nor Apex gives any assurance that either AvePoint or Apex, or the combined company, will achieve its expectations.

No Offer or Solicitation

This press release shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the business combination discussed herein. This press release also shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended, or an exemption therefrom.

Important Information for Investors and Stockholders

This press release relates to a proposed transaction between AvePoint and Apex. In connection with the proposed transaction, Apex has filed a registration statement on Form S-4 with the SEC, also includes a document that serves as a prospectus and proxy statement of Apex, referred to as a proxy statement/prospectus. A proxy statement/prospectus will be sent to all Apex shareholders. Apex will file other documents regarding the proposed transaction with the SEC. Before making any voting decision, investors and security holders of Apex are urged to read the registration statement, the proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC in connection with the proposed transaction as they become available because they will contain important information about the proposed transaction.

Investors and security holders are able to obtain free copies of the registration statement, the proxy statement/prospectus and all other relevant documents filed or that will be filed with the SEC by Apex through the website maintained by the SEC at http://www.sec.gov. The information contained on, or that may be accessed through, the websites referenced in this press release is not incorporated by reference into, and is not a part of, this press release.

Participants in the Solicitation

Apex and its directors and officers may be deemed participants in the solicitation of proxies of Apexs stockholders in connection with the proposed transaction. Apexs stockholders and other interested persons may obtain, without charge, more detailed information regarding the directors and officers of Apex in the registration statement containing the proxy statement/prospectus which has been filed with the SEC.

Year ended December 31,

2020

2019

(in thousands)

$

91,023

$

54,729

34,140

26,662

26,370

34,708

151,533

116,099

12,980

9,397

26,089

24,727

1,221

2,275

40,290

36,399

111,243

79,700

76,545

61,901

36,872

24,614

12,204

11,148

1,059

1,049

Read the original post:

Apex Technology Acquisition Corporation and AvePoint Announce Record Full Year 2020 Financial Results - Business Wire

New York, March 11, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "RNA Analysis/Transcriptomics Market Research Report by Product, by Technology, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p06034013/?utm_source=GNW

Market Statistics:The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global RNA Analysis/Transcriptomics Market is expected to grow from USD 4,015.81 Million in 2020 to USD 6,311.28 Million by the end of 2025.2. The Global RNA Analysis/Transcriptomics Market is expected to grow from EUR 3,521.13 Million in 2020 to EUR 5,533.85 Million by the end of 2025.3. The Global RNA Analysis/Transcriptomics Market is expected to grow from GBP 3,130.29 Million in 2020 to GBP 4,919.60 Million by the end of 2025.4. The Global RNA Analysis/Transcriptomics Market is expected to grow from JPY 428,588.68 Million in 2020 to JPY 673,573.50 Million by the end of 2025.5. The Global RNA Analysis/Transcriptomics Market is expected to grow from AUD 5,831.49 Million in 2020 to AUD 9,164.81 Million by the end of 2025.

Market Segmentation & Coverage:This research report categorizes the RNA Analysis/Transcriptomics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the RNA Analysis/Transcriptomics Market studied across Instruments, Reagents/Consumables, Services, and Software.

Based on Technology, the RNA Analysis/Transcriptomics Market studied across Microarrays, Polymerase Chain Reaction, RNA Interference, and Sequencing.

Based on Application, the RNA Analysis/Transcriptomics Market studied across Clinical Diagnostics, Comparative Transcriptomics, Drug Discovery, and Toxicogenomics.

Based on End User, the RNA Analysis/Transcriptomics Market studied across Academic & Research Institutes, Contract Research Organizations, Hospitals, and Pharmaceutical & Biotechnology Companies.

Based on Geography, the RNA Analysis/Transcriptomics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global RNA Analysis/Transcriptomics Market including Acobiom, Agilent Technologies, Inc., ALLSEQ, INC., BaseClear B.V., Bio-Rad Laboratories, Inc., bioMrieux SA, CD Genomics, Cyagen Biosciences Inc., Fluidigm Corporation, GenXPro GmbH, Illumina, Inc., LC Sciences LLC, Lexogen GmbH, Merck KGaA, Nucleome Informatics Private Limited, Promega Corporation, Psomagen, Inc., Sequentia Biotech SL, Takara Bio USA, Inc., and Thermo Fisher Scientific, Inc..

Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the RNA Analysis/Transcriptomics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:1. What is the market size and forecast of the Global RNA Analysis/Transcriptomics Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global RNA Analysis/Transcriptomics Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global RNA Analysis/Transcriptomics Market?4. What is the competitive strategic window for opportunities in the Global RNA Analysis/Transcriptomics Market?5. What are the technology trends and regulatory frameworks in the Global RNA Analysis/Transcriptomics Market?6. What are the modes and strategic moves considered suitable for entering the Global RNA Analysis/Transcriptomics Market?Read the full report: https://www.reportlinker.com/p06034013/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

More:

RNA Analysis/Transcriptomics Market Research Report by Product, by Technology, by Application, by End User - Global Forecast to 2025 - Cumulative...

A surge in big technology stocks was pulling the stock market sharply higher on Tuesday, as a fall in bond yields was helping beaten-down technology companies recover.

The surge comes a day after the Nasdaq closed 10% below its February peak, what is known as a correction on Wall Street.

The S&P 500 was up 1.8% as of 11:50 a.m. Eastern. The technology-heavy Nasdaq was up 3.3%, led by gains in Apple, Amazon, Facebook and Cisco. The Dow Jones Industrial Average, which is weighted less toward tech than the other two indexes, gained 265 points, or 0.8%, to 32,068. The Russell 2000 index of small company stocks was up 2.3%.

Investors were relieved to see that long-term interest rates were falling in the bond market. The yield on the 10-year Treasury note dropped to 1.55% after trading above 1.60% a day earlier. Higher bond yields tend to pull money away from high-priced stocks like technology companies, which have been soaring through the pandemic.

Bank stocks, which had benefited from the rise in bond yields, were moving in the opposite direction as the rest of the market. Bank of America fell 0.5% while Citigroup was flat.

Yields have been climbing with rising expectations for growth and the inflation that could follow. Higher yields put downward pressure on stocks generally, in part because they can steer away dollars that might have gone into the stock market into bonds instead. That makes investors less willing to pay such high prices for stocks, especially those that look the most expensive, such as technology stocks.

Striking the correction level for the Nasdaq is also important for many investors and traders who use technical indicators to decide when to buy or sell stocks. A correction is typically seen as a healthy moment for any market, giving investors a chance to pause and reallocate their investments without the volatility and stress that a bear market typically can bring.

Investors have been betting that$1.9 trillion in coming government stimuluswill help lift the economy out of its coronavirus-induced malaise. There are also investors who are betting that stimulus and an improving economy will result in some inflation down the road.

The U.S. economic aid package, passed narrowly by the Senate on Saturday, provides direct payments of up to $1,400 for most Americans and extends emergency unemployment benefits. Its a victory for President Joe Biden and his Democratic allies, and final congressional approval is expected this week.

Oil prices were also moving modestly lower, continuing a two-day slide. U.S. crude oil fell 0.8% to $64.24 a barrel.

Read this article:

Technology rebound leads stocks higher in early US trading - FOX40

Roger announced today that it has opened its ecosystem up for all dry bulk truck shippers and carriers to access.

Roger was developed with feedback from more than 500 trucking companies and industry leaders in dry bulk freight shipping. While Roger is less than a year old, more than 150,000 loads have been completed using Roger's technologies, with nearly 500 carriers hauling more than 45 different commodities for major dry bulk shippers like The Andersons Inc., Cargill,Consolidated Grain and Barge Co.,Koch FertilizerandThe Scoular Company. Roger is also backed by one of the industry's leading agricultural technology companies, Bushel.

"Shipper and carrier relationships are important in our business," said Jeff Schreiner, CEO of Roger. "The key to success is being able to build additional business relationships and then use data-driven insights to make informed and profitable business decisions. Roger does just that. It is a neutral and secure solution that uses technology to organize data, create efficiencies, and connect shippers and carriers in a new, more transparent way."

Current bulk freight processes are fragmented and manual, resulting in lost productivity and revenue potential. Roger's technologies aim to solve some of the industry's biggest challenges.

"Rogerhas improved our communication with carriers and partners," said Jeannie Frana, Global Process Owner, Cargill Transportation and Logistics. "We've been able to reduce phone calls, cut back on paperwork and pay our carriers faster. It's a win-win for Cargill and our carriers."

Roger Technology Solutions

Roger is a single, universal technology solution that can integrate with existing systems and be used across the entire industry, giving shippers and carriers tools that can be used together or individually:

"The visibility of our carrier's location allows us to make real-time logistical decisions," said Ryan Napier, Grain Merchandiser, Scoular, "while the paperless billing streamlined the flow of information from carriers to customers, increased our payment turnaround and enabled almost real-time information flow to our customers."

Napier added, "The level of transparency and trust Roger offers is unlike any other platform we've used. Our customers can instantly see the location of their load and the information we have on the load; see as soon as a truck scales out of our facility, when it scales into the destination and when the load is delivered. It has improved the level of customer service we can provide tremendously."

How to Get Onboard

To learn more about how Roger works, view a demo video, or to get started, visit rogerthat.com. The Roger App is available in theApple App Store(search for Roger Trucking) or Google Play Store(search for Roger).

About Roger LLC

Roger LLC develops digital tools to help shippers and carriers unlock the power of their bulk freight networks by digitizing the entire shipping process, from dispatch to payment. Roger's ecosystem was developed working alongside more than 500 trucking companies and the company's initial charter members, The Andersons Inc., Bushel, Cargill,Consolidated Grain and Barge Co.,Koch FertilizerandThe Scoular Company. The company's mission is to create an innovative, neutral and secure technology solution that brings trust and transparency to the bulk freight industry and tackles some of the industry's biggest challenges. Learn more at rogerthat.com.

SOURCE Roger LLC

Home

Originally posted here:

Roger's Technology Is Changing the Way the Bulk Freight Industry Does Business - PRNewswire

Consultants at the University of Southamptons Wolfson Unit have confirmed the validity of UK-based Windship Technologys patented triple wing rig.

The study, which predicted performance reduction for a 125,000DWT vessel, showed that the companys rigged commercial vessels will achieve fuel savings of around 33%.

According to Windship Technology technical director Simon Rogers, the companys True Zero design could eliminate CO2, NOx, SOx and particulate matter by incorporating large solar arrays, carbon capture, optimised hull shapes and specialised weather routing software.

We speak to Rogers about the studys wider implication and how Windship Technologys triple rig will save fuel and reduce commercial vessel emissions.

Simon Rogers (SR): The findings of the Wolfson Unit at the University of Southampton were the result of modelling a 125,000t ship and running the hydrostatic calculations to look at the performance overall and the integration of the computational fluid dynamics results and combining them with the overall performance profile.

What was discovered is that the results were really substantial and at a ship speed of 12 knots, we had about fuel savings of about 33% in a fully loaded condition. We have about 8% better performance in the unloading conditions.

So [between] 10 and 12 knots, were getting nearly 48% in full loaded condition and over 50% in ballast condition. We are likely to be between 35% to 40% fuel saving on a North Atlantic route taking all seasons into account just with wind.

SR:They were conducted by the Wolfson Unit using its in-house velocity prediction programme. Its a piece of software that combines the water side (Hydro) of the analysis with the air side (Aero) and is a commercially recognised and validated piece of software.

GlobalData's TMT Themes 2021 Report tells you everything you need to know about disruptive tech themes and which companies are best placed to help you digitally transform your business.

SR:[The results] demonstrate beyond what we have already predicted, [the cost] of the True Zero solution has actually come out much better than we expected.

With [Windship] we think [we could achieve] fuel savings of over 35% to 40%, so it just further answered the validation that True Zero will be a reality very soon.

SR: [Our product] is three vertical wings and what we were able to do with that is to have a big rotating bearing on the deck. The three vertical wings are 48 inches tall they are bigger than a 380 wing so they are really massive and each one of those fixed wings has four trailing edge flaps.

Its basically three aircraft wings with flaps bolted together and rotating on a bearing to set up the angle of attack. And when the direction of the wind changes, we tack like a sailing boat, changing the canvas section of the back of the rig for the new wind direction.

Its a very powerful system and our solution has the highest power density and height rigs of any wind solution in the world.

SR: Wind Technology alone will be responsible for reducing fuel consumption by conservatively 30%.

In this situation, we are looking at probably nearer 35% to 40% fuel saving. And that is only achievable in new ships, where we have the new drive train as well. We are able to optimise the engine for the thrust that is produced by the rig.

The benefits to the environment are considerable, as the combination with the carbon capture and heat recovery system eliminates the SOx, NOx, the particular matter and all of the CO2.

Thats what we are verifying with DNV at the moment, but it will be an absolute revolution for the industry.

SR: We are planning on building two prototypes. The wing themselves are made out of composite material, very similar to the wind turbine industry.

Its well-proven technology and that can be manufactured in the UK. We will build two prototypes, which will be fitted to an existing ship for trials and at the moment we are working with owners to make this possible.

Its a two-year programme and whilst we are doing prototype testing, we will also be building a factory for production.

Propeller Shaft Seals and Bulkhead Seals

28 Aug 2020

Here is the original post:

Q&A: reducing emissions with Windship Technology - Ship Technology